254 related articles for article (PubMed ID: 20505281)
21. Ultrastructural study of Sjögren's syndrome-like disease in MRL/l mice.
Tanaka A; O'Sullivan FX; Koopman WJ; Gay S
J Oral Pathol; 1988 Nov; 17(9-10):460-5. PubMed ID: 3150433
[TBL] [Abstract][Full Text] [Related]
22. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
[TBL] [Abstract][Full Text] [Related]
23. [Intervention of Yangfei Ziyin Decoction on Sjogren's Syndrome Model Mice].
Tian MJ; Tu ZH; Hu R; Zhu XX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jan; 36(1):63-8. PubMed ID: 26955680
[TBL] [Abstract][Full Text] [Related]
24. Link between inflammation and aquaporin-5 distribution in submandibular gland in Sjögren's syndrome?
Soyfoo MS; Konno A; Bolaky N; Oak JS; Fruman D; Nicaise C; Takiguchi M; Delporte C
Oral Dis; 2012 Sep; 18(6):568-74. PubMed ID: 22320885
[TBL] [Abstract][Full Text] [Related]
25. Abnormal subcellular localization of AQP5 and downregulated AQP5 protein in parotid glands of streptozotocin-induced diabetic rats.
Wang D; Yuan Z; Inoue N; Cho G; Shono M; Ishikawa Y
Biochim Biophys Acta; 2011 May; 1810(5):543-54. PubMed ID: 21295117
[TBL] [Abstract][Full Text] [Related]
26. Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
Yoshimura S; Nakamura H; Horai Y; Nakajima H; Shiraishi H; Hayashi T; Takahashi T; Kawakami A
Mod Rheumatol; 2016; 26(3):384-90. PubMed ID: 26375433
[TBL] [Abstract][Full Text] [Related]
27. Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice.
Zeng M; Szymczak M; Ahuja M; Zheng C; Yin H; Swaim W; Chiorini JA; Bridges RJ; Muallem S
Gastroenterology; 2017 Oct; 153(4):1148-1159. PubMed ID: 28634110
[TBL] [Abstract][Full Text] [Related]
28. Cevimeline enhances the excitability of rat superior salivatory neurons.
Ueda H; Mitoh Y; Ichikawa H; Kobashi M; Yamashiro T; Matsuo R
J Med Invest; 2009; 56 Suppl():267-9. PubMed ID: 20224198
[TBL] [Abstract][Full Text] [Related]
29. Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.
Zhou J; Kawai T; Yu Q
Lab Invest; 2017 Apr; 97(4):458-467. PubMed ID: 28067896
[TBL] [Abstract][Full Text] [Related]
30. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
[TBL] [Abstract][Full Text] [Related]
31. Ezrin Is a Novel Protein Partner of Aquaporin-5 in Human Salivary Glands and Shows Altered Expression and Cellular Localization in Sjögren's Syndrome.
Chivasso C; Hagströmer CJ; Rose KL; Lhotellerie F; Leblanc L; Wang Z; Moscato S; Chevalier C; Zindy E; Martin M; Vanhollebeke B; Gregoire F; Bolaky N; Perret J; Baldini C; Soyfoo MS; Mattii L; Schey KL; Törnroth-Horsefield S; Delporte C
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502121
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren's syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study.
Leung KC; McMillan AS; Wong MC; Leung WK; Mok MY; Lau CS
Clin Rheumatol; 2008 Apr; 27(4):429-36. PubMed ID: 17899308
[TBL] [Abstract][Full Text] [Related]
33. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.
Arisawa H; Imai E; Fujise N; Fukui K; Masunaga H
Arzneimittelforschung; 2002; 52(1):14-20. PubMed ID: 11838269
[TBL] [Abstract][Full Text] [Related]
34. (+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: the role of muscarinic acetylcholine receptors.
Iga Y; Arisawa H; Ogane N; Saito Y; Tomizuka T; Nakagawa-Yagi Y; Masunaga H; Yasuda H; Miyata N
Jpn J Pharmacol; 1998 Nov; 78(3):373-80. PubMed ID: 9869272
[TBL] [Abstract][Full Text] [Related]
35. Effect of cevimeline on salivary components in patients with Sjögren syndrome.
Suzuki K; Matsumoto M; Nakashima M; Takada K; Nakanishi T; Okada M; Ohsuzu F
Pharmacology; 2005 May; 74(2):100-5. PubMed ID: 15722648
[TBL] [Abstract][Full Text] [Related]
36. Calcium signaling and cell volume regulation are altered in Sjögren's Syndrome.
Enger TB; Aure MH; Jensen JL; Galtung HK
Acta Odontol Scand; 2014 Oct; 72(7):549-56. PubMed ID: 24471729
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren's Syndrome.
Zhang LW; Cong X; Zhang Y; Wei T; Su YC; Serrão AC; Brito AR; Yu GY; Hua H; Wu LL
J Dent Res; 2016 Jul; 95(7):784-92. PubMed ID: 26933138
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.
Hauk V; Calafat M; Larocca L; Fraccaroli L; Grasso E; Ramhorst R; Leirós CP
Clin Exp Immunol; 2011 Dec; 166(3):309-16. PubMed ID: 22059987
[TBL] [Abstract][Full Text] [Related]
39. Vasoactive Intestinal Peptide Protects Salivary Glands against Structural Injury and Secretory Dysfunction via IL-17A and AQP5 Regulation in a Model of Sjögren Syndrome.
Li C; Zhu F; Wu B; Wang Y
Neuroimmunomodulation; 2017; 24(6):300-309. PubMed ID: 29617700
[TBL] [Abstract][Full Text] [Related]
40. Cevimeline-induced monophasic salivation from the mouse submandibular gland: decreased Na+ content in saliva results from specific and early activation of Na+/H+ exchange.
Kondo Y; Nakamoto T; Mukaibo T; Kidokoro M; Masaki C; Hosokawa R
J Pharmacol Exp Ther; 2011 Apr; 337(1):267-74. PubMed ID: 21239510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
